Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01255917 · ClinicalTrials.gov registry record
Nerve Growth Factor in Chronic Pancreatitis
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 38
- Enrollment target
NCT01255917 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 38 participants.
The verdict
NCT01255917 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
This study is to understand the role of nerve growth factor(NGF) and other cytokines in the pancreatic fluid of patients with chronic pancreatitis. Hypothesis: 1. Pain does not correlate with changes in the PD morphology suggesting that pain in CP is not only a mechanical problem 2. Pain in CP correlates better with the levels of NGF in the pancreatic juice. NGF is variably expressed in different morphological stages of CP and regulates the sensitivity of the peptidergic nociceptors and is upregulated in pancreatic inflammation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2008-02 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01255917
The ClinicalTrials.gov registry entry for NCT01255917 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01255917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01255917 about?
NCT01255917 is a clinical study titled "Nerve Growth Factor in Chronic Pancreatitis". This study is to understand the role of nerve growth factor(NGF) and other cytokines in the pancreatic fluid of patients with chronic pancreatitis. Hypothesis: 1. Pain does not correlate with changes in the PD morphology suggesting that pain in CP is not only a mechanical problem 2. Pain in CP cor...
What is the current status of trial NCT01255917?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2008-02. Estimated completion is 2011-08.
Who is sponsoring clinical trial NCT01255917?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.